Tzekova Adela, Thuot Ross, Viau Claude
Département de santé environnementale et santé au travail, Université de Montréal, PO Box 6128, QC H3C 3J7 Montréal, Canada.
Arch Toxicol. 2004 Jun;78(6):351-61. doi: 10.1007/s00204-003-0539-7. Epub 2004 Jan 29.
This study was aimed at investigating the correlation between biomarkers of exposure to polycyclic aromatic hydrocarbons and, more specifically, at examining the role of urinary 1-hydroxypyrene (1-OHP) as a reliable measure of internal dose linked to the electrophilic tissue burden (ETB), assessed as covalent binding of the ultimate carcinogen benzo( a)pyrene diolepoxide (BaPDE) with cellular proteins in target organs. The protocol included experimental verification of a previously proposed algorithm for adjustment of reference values for urinary 1-OHP with exposure to different mixtures of polycyclic aromatic hydrocarbons in a rat model. Hence, the relationships between ETB in liver, lung, and heart as well as the BaPDE-haemoglobin adducts level on the one hand, and urinary/faecal 1-OHP or urinary/faecal 3-hydroxybenzo( a)pyrene (3-OHBaP) on the other hand have been examined. Male Sprague-Dawley rats received intraperitoneally, once daily for 10 consecutive days, binary mixtures of benzo( a)pyrene (BaP) and pyrene (P) in three different exposure scenarios corresponding to BaP/P ratios of 0.2, 1 and 5, with three doses of BaP (2, 6 and 20 mg/kg) for each scenario. The ETB levels were measured as the ultimate analyte benzo( a)pyrene tetrol (BaPTeT) obtained after mild acid hydrolysis of BaPDE adducts with proteins. It was experimentally confirmed that: (1) urinary 1-OHP is a reliable biomarker linked to the ETB in tissues that are targets for carcinogenicity, such as lung, for the BaP/P ratios of 0.2 and 1 (linear regression p=0.0099 and 0.0293, respectively); (2) urinary 3-OHBaP is correlated with the BaPDE-haemoglobin adducts for all three exposure scenarios ( p=0.0011 for BaP/P=0.2, p<0.0001 for BaP/P=1 and p=0.0099 for BaP/P=5). The experimental relationship between ETB and urinary 1-OHP was used to interpolate biological limit values for the urinary metabolite assuming three arbitrary critical levels of ETB. These were compared with the values calculated from the algorithm using the BaP/P ratio 1 mixture as a reference. The ratios of calculated to observed values varied from 1.0 to 1.6 for the BaP/P 0.2 mixture, and from 1.9 to 3.0 for the BaP/P 5 mixture. The results obtained in the present study indicate that the algorithm mentioned above applies well for two of the three exposure scenarios corresponding to realistic occupational BaP/P ratios of 0.2 and 1. This suggests that, using ETB as an endpoint, the proposed algorithm will reasonably predict the critical value of urinary 1-OHP for mixtures having different BaP/P ratios. Stronger linear relationships between ETB in all chosen tissues and 1-OHP or 3-OHBaP excretion were obtained with urinary metabolites than with their faecal analogues. Thus urinary 1-OHP and 3-OHBaP are more reliable biomarkers in biological monitoring strategies.
本研究旨在调查多环芳烃暴露生物标志物之间的相关性,更具体地说,是研究尿中1-羟基芘(1-OHP)作为与亲电组织负荷(ETB)相关的内部剂量可靠指标的作用,ETB通过终极致癌物苯并(a)芘二环氧物(BaPDE)与靶器官细胞蛋白的共价结合来评估。该方案包括在大鼠模型中对先前提出的根据多环芳烃不同混合物暴露情况调整尿中1-OHP参考值的算法进行实验验证。因此,一方面研究了肝脏、肺和心脏中的ETB以及BaPDE-血红蛋白加合物水平,另一方面研究了尿/粪便中的1-OHP或尿/粪便中的3-羟基苯并(a)芘(3-OHBaP)之间的关系。雄性Sprague-Dawley大鼠连续10天每天腹腔注射苯并(a)芘(BaP)和芘(P)的二元混合物,三种不同暴露情况对应的BaP/P比例分别为0.2、1和5,每种情况有三种BaP剂量(2、6和20 mg/kg)。ETB水平通过对BaPDE与蛋白质加合物进行温和酸水解后得到的终极分析物苯并(a)芘四醇(BaPTeT)来测量。实验证实:(1)对于BaP/P比例为0.2和1的情况,尿中1-OHP是与致癌性靶组织(如肺)中的ETB相关的可靠生物标志物(线性回归p分别为0.0099和0.0293);(2)在所有三种暴露情况下,尿中3-OHBaP与BaPDE-血红蛋白加合物相关(BaP/P = 0.2时p = 0.0011,BaP/P = 1时p < 0.0001,BaP/P = 5时p = 0.0099)。ETB与尿中1-OHP之间的实验关系用于假设ETB的三个任意临界水平来内插尿代谢物的生物限值。将这些值与使用BaP/P比例1的混合物作为参考通过算法计算得到的值进行比较。对于BaP/P 0.2的混合物,计算值与观测值的比率在1.0至1.6之间,对于BaP/P 5的混合物,该比率在1.9至3.0之间。本研究获得的结果表明,上述算法适用于对应实际职业BaP/P比例0.2和1的三种暴露情况中的两种。这表明,以ETB作为终点,所提出的算法将合理预测不同BaP/P比例混合物的尿中1-OHP临界值。与粪便类似物相比,在所有选定组织中ETB与1-OHP或3-OHBaP排泄之间获得了更强的线性关系。因此,尿中1-OHP和3-OHBaP在生物监测策略中是更可靠的生物标志物。